Table 1.
Clinical Characteristics of 235 Women with DTC
| Clinical characteristics | ||
|---|---|---|
| Age at diagnosis (years) | Mean ± SD | 28 ± 7 |
| Median | 28 | |
| Range | 16–43 | |
| Age at delivery (years) | Mean ± SD | 34 ± 0.4 |
| Median | 34 | |
| Range | 20–45 | |
| Race/ethnicity | Caucasian | 84.3% (198) |
| Asian | 11.9% (28) | |
| Hispanic | 1.3% (3) | |
| African American | 1.3% (3) | |
| Unknown | 1.3% (3) | |
| Time between diagnosis and subsequent pregnancy (years) | Mean ± SD | 4.9 ± 0.3 |
| Median | 3 | |
| Range | 0.1–23 | |
| Initial surgery | Total thyroidectomy | 89.4% (210) |
| Thyroid lobectomy | 10.6% (25) | |
| RAI ablation | Yes | 61.3% (144) |
| No | 38.7% (91) | |
| Histology | Classic papillary | 73.6% (173) |
| Follicular variant, papillary | 19.6% (46) | |
| Poorly differentiated | 3.4% (8) | |
| Follicular | 2.6% (6) | |
| Hürthle cell | 0.9% (2) | |
| Primary tumor size (cm) | Mean ± SD | 2.1 ± 0.1 |
| Median | 1.8 | |
| Range | 0.2–8.5 | |
| Nodal status at diagnosis | N0/Nx | 48.5% (114) |
| N1 | 48.9% (115) | |
| Metastases at diagnosis | M0 | 95.7% (225) |
| M1 | 4.3%(10) | |
| 2009 ATA risk | Low | 15.7% (37) |
| Intermediate | 78.3% (184) | |
| High | 6% (14) | |
| AJCC stage | I | 95.7% (225) |
| II | 4.3% (10) | |
DTC, differentiated thyroid cancer; SD, standard deviation; RAI, radioactive iodine; ATA, American Thyroid Association; AJCC, American Joint Committee on Cancer.